Equities

Purple Biotech Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Purple Biotech Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.585
  • Today's Change0.006 / 1.04%
  • Shares traded89.59k
  • 1 Year change-81.13%
  • Beta0.6147
Data delayed at least 15 minutes, as of Feb 17 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

  • Revenue in USD (TTM)0.00
  • Net income in USD-3.25m
  • Incorporated1968
  • Employees9.00
  • Location
    Purple Biotech Ltd4 Oppenheimer St., Science ParkREHOVOT 7670104IsraelISR
  • Phone+972 39333121
  • Fax+972 35097196
  • Websitehttps://purple-biotech.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
VivoSim Labs Inc140.00k-1.98m5.22m5.00--0.7383--37.26-0.1898-0.18980.0682.710.017--4.5910,769.23-24.12-51.63-34.26-56.4798.57---1,416.43-2,952.99----0.00--32.11-42.0183.04------
Bullfrog AI Holdings Inc116.67k-6.76m5.25m9.00--2.47--45.01-0.6936-0.69360.01190.18660.0319----12,963.33-184.34---233.50--18.76---5,770.66------0.0278---100.00---31.42------
MetaVia Inc0.00-16.22m5.26m9.00--0.5703-----13.88-13.880.002.880.00----0.00-87.87-99.54-167.49-140.07------------0.00-------121.27---48.18--
Calidi Biotherapeutics Inc0.00-25.62m5.61m28.00--0.7812-----9.62-9.620.001.000.00----0.00-194.84---1,279.90-------------58.240.1544------18.49------
Alaunos Therapeutics Inc6.00k-4.03m5.74m1.00--2.02--955.97-2.29-2.290.00341.270.0017----6,000.00-110.67-63.80-145.65-77.93-----67,083.34-7,084.74----0.00--100.00--86.68------
CTT Pharmaceutical Holdings Inc0.00-1.67m5.76m0.00--2.89-----0.0822-0.08220.000.03460.00-------317.2813.49-448.83304.48------------0.00-------3,454.52------
Brainstorm Cell Therapeutics Inc0.00-10.85m5.89m27.00---------1.50-1.500.00-0.69730.00----0.00-637.06-112.30---219.11--------------------32.39------
Purple Biotech Ltd - ADR0.00-3.25m6.03m9.00--0.1596-----1.02-1.020.003.630.00----0.00-8.80-34.27-10.44-37.87------------0.0077------63.58------
enVVeno Medical Corp0.00-21.97m6.11m37.00--0.1829-----37.84-37.840.0050.980.00----0.00-53.09-52.36-56.24-55.28------------0.00------7.22---36.69--
Alzamend Neuro Inc0.00-6.47m6.20m4.00--1.42-----5.71-5.710.001.150.00----0.00-116.49-171.97-144.76-256.71-----------766.930.00------48.68------
Aptorum Group Ltd-100.00bn-100.00bn6.37m1.00--0.2482----------3.15-----------33.06---31.53--1.65---1,009.86----0.2079---100.00---51.09------
Mustang Bio Inc0.00-2.34m6.38m6.00--0.653-----47.37-47.370.001.340.00----0.00-17.59-70.16-224.95-83.31------------0.00------69.47------
Theriva Biologics Inc0.00-26.19m6.50m22.00--0.2783-----5.53-5.530.000.65390.00----0.00-73.83-37.94-99.55-42.02------------0.2025-------39.81------
Creative Medical Technology Holdings Inc6.00k-5.96m6.50m4.00--0.8584--1,083.35-2.87-2.870.00272.170.00091.10--1,500.00-93.58-83.62-98.14--60.0062.58-99,356.66-10,541.1020.70--0.00--22.22-41.85-3.91------
Aptevo Therapeutics Inc0.00-27.95m6.70m37.00--0.296-----306,220.00-306,220.000.0022.670.00----0.00-125.64-47.17-172.77-82.66-------487.43----0.00-------29.38------
Pharmacyte Biotech Inc0.00-8.98m6.90m2.00--0.1297-----1.32-1.320.005.380.00----0.00-12.747.21-13.517.54------------0.00------235.53------
Data as of Feb 17 2026. Currency figures normalised to Purple Biotech Ltd's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.